Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services, and technologies to accelerate the development and commercialization of small molecule therapies. The company offers APIs, advanced intermediates, and enhanced drug delivery products for both branded and generic drugs. Its custom development and manufacturing capabilities include enzymatic biotransformation, highly potent APIs, high-energy chemical synthesis, controlled substances, and formulation of finished dosage form products. Cambrex has extensive experience in developing drug substances for use by customers in toxicology studies, clinical trials, and commercial supply. The company’s comprehensive services include route selection, process and analytical development, process optimization and scale-up, safety assessment, and product formulation.